Article Details
Retrieved on: 2023-10-30 20:09:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
53 LR] Roche announces EMBARK trial in Duchenne muscular dystrophy (DMD) did not reach primary endpoint, but shows positive efficacy outcomes on all ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here